Study guide

17.1 Pediatric Anatomy, Physiology, Airway & Developmental Pharmacology

NBCRNA CRNA Certified Registered Nurse Anesthetist NCE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Cardiovascular, Respiratory & CNS Physiology & Pathophysiology

1.1 Cardiovascular Physiology, Hemodynamics & Ischemic Heart Disease 1.2 Respiratory Physiology, Lung Volumes & Chronic Pulmonary Pathophysiology 1.3 Central & Autonomic Nervous System Physiology & Neurological Disorders

2 Chapter 2: Hepatorenal, Endocrine & Hematologic/Immune Systems

2.1 Renal Physiology, Glomerular Filtration & Acid-Base Balance 2.2 Hepatic Physiology, Drug Clearance & Gastrointestinal Considerations 2.3 Endocrine Disorders, Hematology, Coagulation & Immune Mechanisms

3 Chapter 3: Anesthetic Pharmacology: Inhalation Agents, Intravenous Anesthetics & Sedatives

3.1 Inhalation Anesthetics: Uptake, Distribution, Blood/Gas Solubility & MAC 3.2 Intravenous Hypnotics: Propofol, Etomidate, Ketamine & Barbiturates 3.3 Opioid Agonists/Antagonists, Benzodiazepines & Reversal Pharmacology

4 Chapter 4: Anesthetic Pharmacology: Neuromuscular Blockers, Local Anesthetics & Physics

4.1 Neuromuscular Blocking Agents & Reversal: Anticholinesterases vs Sugammadex 4.2 Local Anesthetics: Mechanism, Potency, Toxicity (LAST) & Vasoconstrictors 4.3 Applied Physics, Gas Laws, Fluid Dynamics & Anesthesia Mathematics

5 Chapter 5: Anesthesia Delivery Systems & Gas Supplies

5.1 Medical Gas Supply Systems, Cylinders, Regulators & Safety Index Systems (PISS/DISS) 5.2 Anesthesia Machine High, Intermediate & Low Pressure Systems & Failsafe Mechanisms 5.3 Vaporizer Technology: Variable-Bypass vs Desflurane Vaporizers & Machine Checkout

6 Chapter 6: Breathing Circuits, CO2 Absorption & Ventilators

6.1 Breathing Circuits: Circle System, Mapleson Classifications & Dead Space 6.2 Carbon Dioxide Absorption: Soda Lime Chemistry, Desiccation, Carbon Monoxide & Compound A 6.3 Anesthesia Ventilators, Pressure/Volume Modes, APL Valves & Waste Gas Scavenging

7 Chapter 7: Airway Equipment & Advanced Airway Instrumentation

7.1 Face Masks, Supraglottic Airways (LMA Types) & Endotracheal Tubes 7.2 Direct Laryngoscopy (Mac/Miller) & Video Laryngoscopy 7.3 Fiberoptic Intubation, Bronchial Blockers, Double-Lumen Tubes & Surgical Airways

8 Chapter 8: Patient Monitoring, Hemodynamics & Electrosurgical Safety

8.1 Noninvasive Monitoring: Pulse Oximetry, Capnography Waveforms & Temperature 8.2 Invasive Hemodynamics: Arterial Lines, CVP & Pulmonary Artery Catheters 8.3 Neuromuscular Monitoring (TOF/PTC), Depth of Anesthesia (EEG/BIS) & Electrical Safety

9 Chapter 9: Preoperative Assessment, Risk Stratification & Preparation

9.1 Preoperative History, Physical Examination & ASA Physical Status Classification 9.2 Cardiac & Pulmonary Risk Stratification, Diagnostic Testing & Optimization 9.3 Preoperative Fasting Guidelines, Aspiration Prophylaxis & Premedication

10 Chapter 10: Fluid Management, Blood Component Therapy & Coagulation Monitoring

10.1 Crystalloids vs Colloids, Maintenance & Deficit Calculations 10.2 Blood Component Therapy, Transfusion Triggers & Massive Transfusion Protocols 10.3 Point-of-Care Coagulation: TEG, ROTEM & Perioperative Coagulopathies

11 Chapter 11: Airway Management Strategies & Difficult Airway Algorithms

11.1 Difficult Airway Assessment: Mallampati, Cormack-Lehane & Airway Predictors 11.2 ASA Difficult Airway Algorithm: Anticipated vs Unanticipated Difficult Airway 11.3 "Cannot Intubate, Cannot Oxygenate" (CICO) & Emergency Front-of-Neck Access (eFONA)

12 Chapter 12: General Anesthesia: Induction, Maintenance, Emergence & TIVA

12.1 Rapid Sequence Induction (RSI), Cricoid Pressure & Intubation Protocols 12.2 Balanced Anesthesia vs Total Intravenous Anesthesia (TIVA) Principles 12.3 Emergence, Extubation Criteria, Deep vs Awake Extubation & Laryngospasm

13 Chapter 13: Regional Anesthesia: Neuraxial Blocks

13.1 Spinal Anesthesia: Anatomy, Physiology, High Spinal & Complications 13.2 Epidural & Combined Spinal-Epidural (CSE) Techniques & PDPH 13.3 Neuraxial Anticoagulation Guidelines (ASRA) & Epidural Hematoma

14 Chapter 14: Regional Anesthesia: Peripheral Nerve Blocks & Ultrasound Guidance

14.1 Upper Extremity Peripheral Nerve Blocks: Interscalene, Supraclavicular, Axillary 14.2 Lower Extremity & Truncal Blocks: Femoral, Sciatic, TAP & ESP Blocks 14.3 Ultrasound Physics, Needle Visualization & LAST Rescue Protocols

15 Chapter 15: Perioperative Safety, Positioning, PACU, Ethics & Professional Practice

15.1 Surgical Positioning Complications: Nerve Injuries & Physiologic Changes 15.2 PACU Discharge Criteria, PONV Management, Hypoxemia & Emergence Delirium 15.3 Malignant Hyperthermia Protocol & Operating Room Crisis Management 15.4 CRNA Ethics, Informed Consent, Scope of Practice & Wellness Initiatives

16 Chapter 16: Obstetric & Gynecologic Anesthesia

16.1 Maternal Physiology & Pharmacokinetics Across Trimesters 16.2 Labor Analgesia & Anesthesia for Cesarean Delivery 16.3 Obstetric Emergencies: Preeclampsia, Hemorrhage & Amniotic Fluid Embolism 16.4 Nonobstetric Surgery in the Pregnant Patient

17 Chapter 17: Pediatric Anesthesia

17.1 Pediatric Anatomy, Physiology, Airway & Developmental Pharmacology 17.2 Pediatric Induction, Maintenance, Fluids & Emergence Agitation 17.3 Pediatric Respiratory Emergencies: Croup, Epiglottitis & Laryngospasm

18 Chapter 18: Geriatric, Bariatric & Ambulatory Anesthesia

18.1 Geriatric Physiology, Pharmacodynamics & Postoperative Delirium/POCD 18.2 Bariatric Anesthesia: Obesity Hypoventilation, OSA & Dosing Adjustments 18.3 Ambulatory Surgery Selection Criteria & ERAS Protocols

19 Chapter 19: Cardiac, Vascular & Thoracic Anesthesia

19.1 Valvular Heart Disease, CAD & Cardiopulmonary Bypass Management 19.2 Vascular Anesthesia: Carotid Endarterectomy & Aortic Cross-Clamping 19.3 Thoracic Anesthesia: One-Lung Ventilation & Hypoxic Pulmonary Vasoconstriction

20 Chapter 20: Neurosurgical, Intra-Abdominal, Extrathoracic, Head/Neck & Trauma Anesthesia

20.1 Neurosurgical Anesthesia: ICP Dynamics, Craniotomy & Venous Air Embolism 20.2 Intra-Abdominal, Laparoscopy & Endocrine Tumor Anesthesia (Pheochromocytoma, Carcinoid) 20.3 ENT/Shared Airway, Extrathoracic Procedures & Trauma/Burn Resuscitation

21 Chapter 21: Neurologic, Gastrointestinal & Substance-Related Pathophysiology and Pharmacology

21.1 Neurodegenerative & Demyelinating Disease and Antiparkinsonian Pharmacology 21.2 Gastrointestinal & Exocrine Pancreatic Disorders: Esophageal, Gastric, Pancreatitis & Malabsorption 21.3 Cannabinoids, Herbal Remedies & Dietary Supplements

22 Chapter 22: Imaging Safety, Patient Warming & Infusion Technology

22.1 Fluoroscopy, Radiography & Radiation Safety in Anesthetizing Locations 22.2 Patient Warming Equipment & Rapid Infusion Devices

23 Chapter 23: Pain Medicine: Theory, Chronic Pain & Interventional Procedures

23.1 Pain Theory: Nociception, Sensitization & Chronic Pain Pathophysiology 23.2 Chronic Pain Management, Medication-Assisted Therapy & the Opioid-Tolerant Patient 23.3 Interventional Pain Procedures & Anesthesia for Pain Management Cases

24 Chapter 24: Professional Practice: Research Ethics, Error Disclosure & Provider Infection Control

24.1 Research Ethics, IRB Oversight & Protection of Human Subjects 24.2 Disclosure of Errors and Injuries, Adverse Event Reporting & Just Culture 24.3 Provider Infection Control: PPE, Air Handling & Occupational Exposure

25 Chapter 25: Neurosurgical Subspecialty Procedures

25.1 Cerebral Aneurysm Clipping, AVM Resection & Subarachnoid Hemorrhage 25.2 Transsphenoidal Hypophysectomy & Pituitary Surgery 25.3 Stereotactic Procedures, Deep Brain Stimulation & Awake Craniotomy 25.4 CSF Diversion, Burr Holes, Ventriculoperitoneal Shunts & Decompressive Craniectomy

26 Chapter 26: Head, Neck, Nasal, Dental & Ophthalmic Anesthesia

26.1 Nasal & Sinus Surgery, Nasotracheal Intubation & Craniofacial Procedures 26.2 Dental, Orthodontic, Oral-Maxillofacial & Ophthalmic Anesthesia 26.3 Neck Tumors, Radical Neck Dissection, Lymph Node Biopsy & Thyroid/Parathyroid Surgery

27 Chapter 27: Orthopedic & Extremity Anesthesia

27.1 Total Joint Arthroplasty, Bone Cement Implantation Syndrome & Tourniquet Physiology 27.2 Closed Reduction, Hand and Foot Procedures & Intravenous Regional (Bier) Block

28 Chapter 28: Non-Operating-Room Anesthesia: Interventional, Imaging & Radiation Therapy

28.1 Interventional and Neurointerventional Radiology Anesthesia 28.2 Radiation Therapy, Diagnostic Imaging & MRI-Suite Anesthesia

29 Chapter 29: Special Populations: Substance Use Disorder, Immunocompromised & Oncology Patients

29.1 Acute Intoxication, Withdrawal Syndromes & Perioperative Complications 29.2 Anesthesia for the Immunocompromised & Oncology Patient

17.1 Pediatric Anatomy, Physiology, Airway & Developmental Pharmacology

Key Takeaways Explain This Topic AI

The pediatric airway is anatomically distinct: a large occiput necessitates a shoulder roll (rather than head elevation) to achieve a neutral sniffing position, a relatively large tongue easily causes pharyngeal obstruction, the larynx is cephalad at C3-C4 (versus C4-C5 in adults), the epiglottis is long, floppy, and U- or omega-shaped (requiring direct elevation with a straight Miller blade), and the narrowest point of the funnel-shaped airway is the nondistensible cricoid cartilage.

Oxygen consumption in neonates and infants is 6 to 8 mL/kg/min (double the adult rate of 3 to 4 mL/kg/min) while Functional Residual Capacity (FRC) is only ~30 mL/kg, creating a high alveolar ventilation-to-FRC ratio (5:1 vs 1.5:1 in adults) that causes arterial oxygen desaturation to occur within 30 to 45 seconds of apnea.

The infant myocardium has disorganized myofibrils and a stiff, non-compliant left ventricle with fixed stroke volume, rendering cardiac output entirely heart rate-dependent (CO = HR × fixed SV); autonomic control is dominated by the parasympathetic system, making bradycardia the primary and most dangerous cardiovascular response to hypoxia, vagal stimulation, or succinylcholine.

Total body water (TBW) represents 75% to 80% of body weight in neonates (with extracellular fluid at ~40%), expanding the volume of distribution (Vd) for water-soluble drugs and necessitating higher weight-based loading doses (Succinylcholine 2 mg/kg IV or 4 mg/kg IM; Rocuronium 1.0-1.2 mg/kg IV for RSI).

Minimum Alveolar Concentration (MAC) is age-dependent, peaking in infants aged 1 to 6 months (Sevoflurane MAC reaches 3.2% to 3.3%) before declining steadily through childhood and adulthood; inhalational wash-in (FA/FI ratio rise) is markedly accelerated in infants due to high minute ventilation relative to FRC, lower tissue/blood solubility, and preferential cardiac output distribution to vessel-rich organs.

Last updated: August 2026

17.1 Pediatric Anatomy, Physiology, Airway & Developmental Pharmacology

Pediatric anesthesia requires a comprehensive understanding of developmental anatomy, transitional physiology, and age-dependent pharmacology. Infants and neonates are not merely "small adults"; their unique anatomical proportions, cardiopulmonary mechanics, and body fluid distribution create distinct clinical challenges requiring specialized airway techniques and precise pharmacologic dosing.

1. Anatomical Distinctions of the Pediatric Airway

From the neonate through early childhood, upper airway structures undergo continuous morphological transformation. Recognizing these specific anatomical differences is vital for effective bag-valve-mask ventilation, direct laryngoscopy, and endotracheal tube selection. +---------------------------------------------------------------------------------------------------------+

  • | ADULT VS. PEDIATRIC AIRWAY ANATOMY |
  • +-----------------------+------------------------------------+--------------------------------------------+
  • | Anatomical Feature | Infant / Child | Adult |
  • +-----------------------+------------------------------------+--------------------------------------------+
  • | **Occiput** | • Prominent, large occiput | • Flat, proportional occiput |
  • | | • Causes neck flexion when supine | • Neutral head position when supine |
  • | | • **Correction: Shoulder roll** | • **Correction: Pillow under head** |
  • +-----------------------+------------------------------------+--------------------------------------------+
  • | **Tongue** | • Disproportionately large | • Proportional to oral cavity size |
  • | | • Prone to posterior displacement | • Less prone to isolated soft-tissue |
  • | | • Fills oropharyngeal vault | obstruction in neutral position |
  • +-----------------------+------------------------------------+--------------------------------------------+
  • | **Nasal Passages** | • Narrow, obligate nasal breathers | • Wide, preferential oronasal breathers |
  • | | up to 3 - 6 months of age | • Choanal passages accommodate airways |
  • +-----------------------+------------------------------------+--------------------------------------------+
  • | **Epiglottis** | • Long, narrow, "U" or "Omega" (Ω) | • Broad, flat, flexible |
  • | | shaped, stiff and angled 45° | • Parallel to tracheal axis |
  • | | posteriorly over glottis | • Easily elevated indirectly via vallecula |
  • +-----------------------+------------------------------------+--------------------------------------------+
  • | **Laryngeal Level** | • Cephalad: **C3 - C4** in infants | • Caudad: **C4 - C5** (adult female) |
  • | | • **C3** in premature neonates | or **C5 - C6** (adult male) |
  • +-----------------------+------------------------------------+--------------------------------------------+
  • | **Vocal Cords** | • Sloped with anterior attachment | • Perpendicular / horizontal relative to |
  • | | lower than posterior attachment | the long axis of the trachea |
  • +-----------------------+------------------------------------+--------------------------------------------+
  • | **Airway Shape &** | • **Funnel-shaped (conical)** | • **Cylindrical** |
  • | **Narrowest Point** | • Narrowest at **cricoid ring** | • Narrowest at **vocal cords (glottis)** |
  • +-----------------------+------------------------------------+--------------------------------------------+
  • | **Submandibular** | • Soft, easily compressed | • Bony support prevents soft tissue |
  • | **Tissue Space** | • Mask pressure collapses tongue | collapse during mask ventilation |

+-----------------------+------------------------------------+--------------------------------------------+ [LARYNGEAL CONFIGURATION & NARROWEST POINT]

  • PEDIATRIC (CONICAL / FUNNEL) ADULT (CYLINDRICAL)
  • [Vocal Cords] [Vocal Cords]
  • / \ | |
  • / Glot \ | Gl | <--- Narrowest Point
  • / tis \ | |
  • / \ | |
  • / Thyroid \ | |
  • / Cartilage \ | |
  • | | | |
  • | CRICOID RING | <--- Narrowest Point | |
  • | (Inelastic) | | |
  • \ / | |
  • \ Trachea / | |
  • Clinical Implications of Airway Differences

Head Positioning: In an infant, the large prominent occiput forces the cervical spine into flexion when placed flat on an operating table, resulting in immediate airway occlusion. Placing a small shoulder roll (folded towel) under the infant's shoulders aligns the oral, pharyngeal, and laryngeal axes into a neutral "sniffing" position. Elevating the head with a pillow (as in adults) worsens flexion and upper airway obstruction.

Laryngoscope Blade Selection: Because the pediatric epiglottis is long, narrow, floppy, and angled sharply posteriorly over the glottic aperture, a straight blade (Miller) is preferred in neonates and infants under 2 to 3 years of age. The tip of the Miller blade is passed directly posterior to the epiglottis to lift it anteriorly out of the line of sight. Attempting to use a curved (Macintosh) blade in the vallecula often fails because the loose hyoepiglottic ligament cannot effectively transmit traction to lift the floppy epiglottis.

Cricoid Vulnerability: The cricoid cartilage forms the only complete, nondistensible cartilaginous ring in the human airway. In children under 8 to 10 years of age, the subglottic lumen at the cricoid ring is the narrowest anatomical aperture. Inserting an oversized endotracheal tube exerts direct pressure on the delicate, highly vascular subglottic mucosa, leading to mucosal ischemia, reactive edema, post-extubation croup, and potential subglottic stenosis.

2. Pediatric Respiratory Physiology & Gas Exchange

Pediatric respiratory mechanics are characterized by high metabolic demands placed on an anatomically and mechanically disadvantaged pulmonary system. +---------------------------------------------------------------------------------------------------------+

  • | RESPIRATORY PHYSIOLOGIC COMPARISON TABLE |
  • +-------------------------------------+-----------------------------+-------------------------------------+
  • | Physiologic Parameter | Infant (Neonate / <1 Year) | Adult |
  • +-------------------------------------+-----------------------------+-------------------------------------+
  • | **Oxygen Consumption (VO₂)** | **6 - 8 mL/kg/min** | **3 - 4 mL/kg/min** |
  • | **Carbon Dioxide Production (VCO₂)**| **6 - 8 mL/kg/min** | **3 mL/kg/min** |
  • | **Alveolar Ventilation (VA)** | **100 - 150 mL/kg/min** | **60 mL/kg/min** |
  • | **Functional Residual Capacity** | **~30 mL/kg** (static) | **~30 - 35 mL/kg** |
  • | **VA / FRC Ratio** | **5:1** (very high) | **1.5:1** |
  • | **Tidal Volume (Vt)** | **6 - 8 mL/kg** | **6 - 8 mL/kg** |
  • | **Respiratory Rate (RR)** | **30 - 50 breaths/min** | **12 - 16 breaths/min** |
  • | **Chest Wall Compliance** | Extremely High (Cartilage) | Moderate (Bony thorax) |
  • | **Lung Compliance** | Low (Poor elastic recoil) | High (Well-developed alveoli) |
  • | **Diaphragmatic Muscle Fibers** | **10 - 25% Type I (slow)** | **50 - 55% Type I (slow)** |
  • +-------------------------------------+-----------------------------+-------------------------------------+
  • Mechanisms of Rapid Desaturation

Neonates and young infants desaturate precipitously (often within 30 to 45 seconds ) upon cessation of ventilation. This phenomenon is driven by three interconnected physiologic factors:

High Metabolic Rate ( V O 2 VO_2 V O 2 ​ ): Resting oxygen consumption ( 6 − 8 mL/kg/min 6 - 8 \text{ mL/kg/min} 6 − 8 mL/kg/min ) is twice that of adults, rapidly depleting available oxygen stores during apnea.

Small Oxygen Reservoir ( V A / FRC V_A/\text{FRC} V A ​ / FRC Ratio): Although FRC per kilogram is similar between infants and adults ( 30 mL/kg ~30 \text{ mL/kg} 30 mL/kg ), the high alveolar ventilation relative to FRC ( 5 : 1 5:1 5 : 1 vs 1.5 : 1 1.5:1 1.5 : 1 ) means the infant lung contains very little stored oxygen relative to turnover.

Closing Capacity Exceeding FRC: In infants, the Closing Capacity (CC) is higher than FRC during resting tidal breathing. As a result, small terminal airways collapse during normal end-expiration, producing baseline ventilation-perfusion ( V / Q V/Q V / Q ) mismatch, micro-atelectasis, and significant intrapulmonary shunting. Desaturation Rate ∝ Metabolic Oxygen Consumption ( V O 2 ) Functional Residual Capacity ( FRC ) \text{Desaturation Rate} \propto \frac{\text{Metabolic Oxygen Consumption } (VO_2)}{\text{Functional Residual Capacity } (\text{FRC})} Desaturation Rate ∝ Functional Residual Capacity ( FRC ) Metabolic Oxygen Consumption ( V O 2 ​ ) ​

Mechanics of the Chest Wall and Diaphragm

Cartilaginous Rib Cage: The infant thorax consists largely of pliable cartilage with horizontal rib insertion. This high chest wall compliance fails to provide outward recoil against inward lung elastic forces. During respiratory distress or upper airway obstruction, forceful diaphragmatic contraction generates negative intrathoracic pressure that pulls the compliant chest wall inward, producing sternal and intercostal retractions (paradoxical breathing) rather than expanding lung volume.

Diaphragmatic Fatigue: The infant diaphragm contains only 10 % − 25 % 10\% - 25\% 10% − 25% Type I (slow-twitch, fatigue-resistant) muscle fibers compared to 50 % − 55 % 50\% - 55\% 50% − 55% in adults. When respiratory workload increases, infants rapidly develop diaphragmatic muscle fatigue, hypoventilation, hypercapnia, and respiratory arrest.

Control of Breathing: Neonatal central chemoreceptors exhibit a biphasic hypoxic ventilatory response : exposure to hypoxemia produces a brief (1-minute) increase in ventilation followed immediately by sustained respiratory depression and central apnea . Preterm infants are especially prone to apnea of prematurity until 52 to 60 weeks post-conceptual age (PCA).

3. Cardiovascular Physiology & Hemodynamic Regulation

The neonatal and pediatric cardiovascular system operates near the peak of its functional capacity under baseline conditions. +---------------------------------------------------------------------------------------------------------+

  • | CARDIOVASCULAR DEVELOPMENTAL PROFILE |
  • +---------------------------+------------------------------------+----------------------------------------+
  • | Physiologic Feature | Infant / Neonate | Adult |
  • +---------------------------+------------------------------------+----------------------------------------+
  • | **Ventricular Compliance**| • Stiff, non-compliant LV/RV | • Highly compliant left ventricle |
  • | | • Immature, disorganized myofibrils| • Organized sarcomere architecture |
  • | **Stroke Volume (SV)** | • **Fixed** (~1 - 1.5 mL/kg) | • Dynamic (can double/triple with vol) |
  • | **Cardiac Output (CO)** | • **Heart rate-dependent** | • Stroke volume and heart rate-driven |
  • | **Autonomic Tone** | • **Parasympathetic (vagal) dom.** | • Balanced sympathetic/parasympathetic |
  • | | • Sympathetic innervation immature | • Robust baroreceptor reflexes |
  • | **Baseline Heart Rate** | • 120 - 160 bpm (Neonate) | • 60 - 100 bpm |
  • | | • 100 - 140 bpm (Infant) | |
  • | **Normal Blood Pressure** | • 60-75 / 35-45 mmHg (Neonate) | • 120 / 80 mmHg |
  • | | • 80-100 / 50-65 mmHg (Child) | |
  • +---------------------------+------------------------------------+----------------------------------------+
  • The Heart Rate-Dependent Cardiac Output

Because the neonatal myocardium is non-compliant and contains fewer organized contractile elements, it cannot significantly increase stroke volume in response to volume administration (underdeveloped Frank-Starling relationship): Cardiac Output = Heart Rate × Fixed Stroke Volume \text{Cardiac Output} = \text{Heart Rate} \times \text{Fixed Stroke Volume} Cardiac Output = Heart Rate × Fixed Stroke Volume

Significance of Bradycardia: Any reduction in heart rate directly produces an equivalent drop in cardiac output and systemic blood pressure. In pediatric anesthesia, bradycardia ( < 100 bpm <100 \text{ bpm} < 100 bpm in infants, < 80 bpm <80 \text{ bpm} < 80 bpm in young children) is an absolute medical emergency and is considered secondary to hypoxia until proven otherwise.

Vagal Predominance: The parasympathetic nervous system is fully functional at birth, whereas sympathetic innervation of the heart and vascular smooth muscle is incomplete. Stimulation of the upper airway (laryngoscopy, suctioning), traction on extraocular muscles (oculocardiac reflex), peritoneal traction, or administration of succinylcholine triggers profound reflex bradycardia or sinus arrest. Pretreatment with Atropine ( 0.02 mg/kg 0.02 \text{ mg/kg} 0.02 mg/kg IV/IM, minimum 0.1 mg 0.1 \text{ mg} 0.1 mg ) or Glycopyrrolate is critical when vagal stimuli are anticipated.

4. Developmental Pharmacology & Pharmacokinetics

Age-related variations in body fluid compartments, plasma protein concentrations, hepatic enzyme maturity, and renal clearance fundamentally alter drug pharmacokinetics. +---------------------------------------------------------------------------------------------------------+

  • | PHARMACOKINETIC PARAMETER COMPARISON |
  • +-----------------------+------------------------+-----------------------+--------------------------------+
  • | Parameter | Premature / Neonate | Infant (1 - 12 mo) | Adult |
  • +-----------------------+------------------------+-----------------------+--------------------------------+
  • | **Total Body Water** | **80 - 85%** of weight | **70 - 75%** | **55 - 60%** |
  • | **Extracellular Fluid**| **40 - 45%** of weight| **30%** | **20%** |
  • | **Body Fat Content** | **1 - 12%** | **15 - 20%** | **18 - 25%** |
  • | **Muscle Mass** | **20%** | **25%** | **40 - 45%** |
  • | **Albumin Level** | Low (decreased) | Near adult by 6-12 mo | Normal (3.5 - 5.0 g/dL) |
  • | **α₁-Acid Glycoprotein**| Very Low | Reaches adult at 1 yr | Normal (50 - 120 mg/dL) |
  • | **CYP450 Enzymes** | ~20 - 40% of adult | Maturing (rapid) | 100% baseline |
  • | **GFR / Renal Clear.**| ~30% (matures at 1 yr) | Matures to adult | Normal (100 - 120 mL/min/1.73m²|

+-----------------------+------------------------+-----------------------+--------------------------------+ [BODY COMPOSITION & VOLUME OF DISTRIBUTION]

  • NEONATE (80% WATER) ADULT (60% WATER)
  • +---------------------------+ +---------------------------+
  • | Extracellular Fluid | | Extracellular Fluid |
  • | (40%) | | (20%) |
  • | | +---------------------------+
  • +---------------------------+ | |
  • | Intracellular Fluid | | Intracellular Fluid |
  • | (40%) | | (40%) |
  • +---------------------------+ | |
  • | Fat (3-12%) | Muscle(20%) | +---------------------------+
  • +---------------------------+ | Fat (20%) | Muscle(40%) |
  • +---------------------------+
  • Volume of Distribution ( V d V_d V d ​ ) & Dosing Rules

Water-Soluble Drugs: Because neonates and infants have an expanded ECF and total body water compartment, hydrophilic medications distribute into a much larger volume. Consequently, larger weight-based initial loading doses are required to achieve target plasma receptor concentrations:

Succinylcholine: Dose is 2.0 mg/kg 2.0 \text{ mg/kg} 2.0 mg/kg IV in neonates/infants (vs 1.0 mg/kg 1.0 \text{ mg/kg} 1.0 mg/kg in adults) or 4.0 mg/kg 4.0 \text{ mg/kg} 4.0 mg/kg IM if IV access is absent.

Rocuronium: Rapid sequence intubation dose is 1.0 − 1.2 mg/kg 1.0 - 1.2 \text{ mg/kg} 1.0 − 1.2 mg/kg IV (vs 0.6 − 1.0 mg/kg 0.6 - 1.0 \text{ mg/kg} 0.6 − 1.0 mg/kg in adults).

Protein Binding: Circulating concentrations of albumin (which binds acidic drugs like thiopental, diazepam, and bupivacaine) and α 1 \alpha_1 α 1 ​ -acid glycoprotein (which binds basic drugs like lidocaine, ropivacaine, and synthetic opioids) are significantly reduced in neonates. Lower protein binding results in a higher free (unbound) fraction of active drug , increasing clinical potency and elevating the risk of local anesthetic systemic toxicity (LAST).

Hepatic and Renal Clearance: Hepatic cytochrome P450 enzymes and Phase II conjugation pathways (glucuronidation) operate at reduced capacity in neonates. Glomerular filtration rate (GFR) and tubular secretion are approximately 30 % 30\% 30% of adult values at birth, reaching mature levels between 8 and 12 months of age. Maintenance doses of renally excreted drugs (e.g., pancuronium, antibiotics) or hepatically metabolized drugs must be reduced or given at extended intervals.

5. Inhalational Anesthetic Kinetics & Age-Dependent MAC

Inhalational induction and emergence occur significantly faster in infants than in adults due to specific kinetic advantages: +---------------------------------------------------------------------------------------------------------+

  • | FACTORS ACCELERATING INHALATIONAL INDUCTION IN INFANTS |
  • +------------------------------------+--------------------------------------------------------------------+
  • | Pharmacokinetic Factor | Mechanism of Action in Pediatrics |
  • +------------------------------------+--------------------------------------------------------------------+
  • | **1. High Minute Ventilation to** | • Alveolar turnover is 3-fold higher ($V_A/\text{FRC} = 5:1$), |
  • | ** FRC Ratio ($V_A/\text{FRC}$)**| rapidly replacing lung volume with anesthetic gas ($F_A/F_I$). |
  • +------------------------------------+--------------------------------------------------------------------+
  • | **2. Greater Blood Flow to VRG** | • Vessel-Rich Group (brain, heart, liver, kidneys) receives |
  • | | **~18%** of cardiac output in infants vs ~10% in adults. |
  • +------------------------------------+--------------------------------------------------------------------+
  • | **3. Lower Blood:Gas Solubility** | • Blood-gas partition coefficients are ~18-20% lower in neonates |
  • | | due to lower serum cholesterol, albumin, and triglycerides. |
  • +------------------------------------+--------------------------------------------------------------------+
  • | **4. Lower Tissue:Blood Solubility**| • Immature muscle and adipose tissue have higher water content, |
  • | | saturating rapidly and minimizing tissue redistribution. |
  • +------------------------------------+--------------------------------------------------------------------+
  • The Age-Dependent MAC Curve

Minimum Alveolar Concentration (MAC) changes throughout the human lifespan in a characteristic inverted-U trajectory:

Neonates ( < 30 <30 < 30 days): MAC is slightly lower than in infants due to central nervous system immaturity, high levels of endogenous circulating endorphins, and residual maternal progesterone.

Infants ( 1 − 6 1 - 6 1 − 6 months): MAC reaches its lifetime maximum . Sevoflurane MAC peaks at 3.2 % − 3.3 % 3.2\% - 3.3\% 3.2% − 3.3% , Isoflurane at 1.6 % − 1.8 % 1.6\% - 1.8\% 1.6% − 1.8% , and Desflurane at 9.0 % − 10.0 % 9.0\% - 10.0\% 9.0% − 10.0% .

Children ( 1 − 12 1 - 12 1 − 12 years): MAC gradually decreases with age (Sevoflurane MAC ≈ 2.5 % \approx 2.5\% ≈ 2.5% ).

Adults & Elderly: Sevoflurane MAC is ≈ 2.0 % \approx 2.0\% ≈ 2.0% in a 40-year-old and decreases by ≈ 6 % \approx 6\% ≈ 6% per decade of life thereafter. [SEVOFLURANE MAC ACROSS THE LIFESPAN]

  • MAC (%)
  • 4.0 |
  • | [Peak: 1 - 6 Months]
  • 3.5 | **3.2 - 3.3%**
  • | / \
  • 3.0 | [Neonate: ~3.0%] \ [Child 1-12 yr: 2.5%]
  • | \ \
  • 2.0 | \-----------> \ [Adult: 2.0%]
  • | \-----> [Elderly: 1.5%]
  • 1.0 |_____________________________________________________________________
  • Birth 1-6 mo 1 yr 5 yr 12 yr 40 yr 80 yr

Loading diagram... Pediatric vs Adult Airway & Cardiopulmonary Comparative Schema